Yunping Luo

5.1k total citations · 2 hit papers
69 papers, 4.0k citations indexed

About

Yunping Luo is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Yunping Luo has authored 69 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Immunology, 34 papers in Molecular Biology and 21 papers in Oncology. Recurrent topics in Yunping Luo's work include Immunotherapy and Immune Responses (23 papers), Immune cells in cancer (17 papers) and Cancer Research and Treatments (10 papers). Yunping Luo is often cited by papers focused on Immunotherapy and Immune Responses (23 papers), Immune cells in cancer (17 papers) and Cancer Research and Treatments (10 papers). Yunping Luo collaborates with scholars based in China, United States and Taiwan. Yunping Luo's co-authors include Rong Xiang, Zhaojun Duan, Ralph A. Reisfeld, Dorothy Markowitz, Tsung‐Hsien Chuang, Debbie Liao, He Zhou, Noriko Mizutani, Masato Mizutani and Guann‐Yi Yu and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Yunping Luo

67 papers receiving 4.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Targeting macrophages in cancer immunotherapy

2021 431 citations Zhaojun Duan, Yunping Luo profile →
Targeting carnitine palmitoyl transferase 1A (CPT1A) induces ferroptosis and synergizes with immunotherapy in lung cancer

2024 84 citations Jiayu Jiang, Zhaojun Duan et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yunping Luo China	34	1.9k	1.8k	1.4k	885	479	69	4.0k
Munitta Muthana United Kingdom	24	1.5k 0.8×	1.6k 0.9×	1.2k 0.8×	563 0.6×	479 1.0×	65	3.7k
Andrea Facciabene United States	25	1.4k 0.7×	2.0k 1.1×	2.0k 1.4×	562 0.6×	325 0.7×	57	3.8k
Jim Xiang Canada	41	2.7k 1.4×	2.9k 1.6×	1.5k 1.1×	821 0.9×	386 0.8×	186	5.4k
Stefanie K. Wculek Spain	18	1.6k 0.9×	2.8k 1.6×	1.8k 1.3×	475 0.5×	536 1.1×	21	4.7k
Bo Huang China	27	2.3k 1.2×	2.1k 1.2×	964 0.7×	1.5k 1.6×	637 1.3×	55	4.5k
Jeff H. Tsai United States	16	2.3k 1.2×	1.2k 0.7×	1.8k 1.2×	1.0k 1.1×	435 0.9×	20	4.8k
Matteo Bellone Italy	36	1.8k 0.9×	2.6k 1.5×	1.6k 1.1×	604 0.7×	198 0.4×	110	4.6k
Mary M. Tomayko United States	21	1.2k 0.6×	1.8k 1.0×	1.0k 0.7×	389 0.4×	225 0.5×	41	4.0k
Mouldy Sioud Norway	42	4.5k 2.3×	2.4k 1.4×	856 0.6×	949 1.1×	337 0.7×	205	6.9k
Arthur E. Frankel United States	40	2.6k 1.3×	2.5k 1.4×	1.4k 1.0×	495 0.6×	464 1.0×	144	5.2k

Countries citing papers authored by Yunping Luo

Since Specialization

Citations

This map shows the geographic impact of Yunping Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yunping Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yunping Luo more than expected).

Fields of papers citing papers by Yunping Luo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yunping Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yunping Luo. The network helps show where Yunping Luo may publish in the future.

Co-authorship network of co-authors of Yunping Luo

This figure shows the co-authorship network connecting the top 25 collaborators of Yunping Luo. A scholar is included among the top collaborators of Yunping Luo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yunping Luo. Yunping Luo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Jiang, Jiayu, Tong Li, Chen Zhang, et al.. (2025). PRTN3 promotes IL33/Treg-mediated tumor immunosuppression by enhancing the M2 polarization of tumor-associated macrophages in lung adenocarcinoma. Cancer Letters. 616. 217584–217584. 3 indexed citations

Duan, Zhaojun, et al.. (2023). The G allele of SNP rs3922 reduces the binding affinity between IGF2BP3 and CXCR5 correlating with a lower antibody production. European Journal of Immunology. 53(8). e2250261–e2250261. 1 indexed citations

Wang, Ziyuan, Chen Zhang, Jian Guo, et al.. (2023). Exosomal miRNA-223-3p derived from tumor associated macrophages promotes pulmonary metastasis of breast cancer 4T1 cells. Translational Oncology. 35. 101715–101715. 20 indexed citations

Chen, Xiaohong, et al.. (2020). LncRNA ZNF667-AS1 Promotes ABLIM1 Expression by Adsorbing microRNA-1290 to Suppress Nasopharyngeal Carcinoma Cell Progression. SHILAP Revista de lepidopterología. 1 indexed citations

Luo, Yunping, et al.. (2020). The effect of PD-1 expression on tumor-associated macrophage in T cell lymphoma. Clinical & Translational Oncology. 23(6). 1134–1141. 19 indexed citations

Ding, Hao, et al.. (2019). Linc00467 promotes lung adenocarcinoma proliferation via sponging miR-20b-5p to activate CCND1 expression. SHILAP Revista de lepidopterología. 2 indexed citations

Hao, Na, Wenzhi Shen, Renle Du, et al.. (2019). Phosphodiesterase 3A Represents a Therapeutic Target that Drives Stem Cell–like Property and Metastasis in Breast Cancer. Molecular Cancer Therapeutics. 19(3). 868–881. 22 indexed citations

Chen, Chong, Lipeng Bai, Shengnan Wang, et al.. (2019). Targeting LIN28B reprograms tumor glucose metabolism and acidic microenvironment to suppress cancer stemness and metastasis. Oncogene. 38(23). 4527–4539. 71 indexed citations

Chen, Yanan, Wenjuan Gao, Antao Chang, et al.. (2017). Liposomal Nanoparticles Carrying anti-IL6R Antibody to the Tumour Microenvironment Inhibit Metastasis in Two Molecular Subtypes of Breast Cancer Mouse Models. Theranostics. 7(3). 775–788. 61 indexed citations

10.

Chen, Chong, Lipeng Bai, Yan Liu, et al.. (2015). IKKβ Enforces a LIN28B/TCF7L2 Positive Feedback Loop That Promotes Cancer Cell Stemness and Metastasis. Cancer Research. 75(8). 1725–1735. 43 indexed citations

11.

Shen, Long, Kunhua Qin, Dekun Wang, et al.. (2014). Overexpression of Oct4 suppresses the metastatic potential of breast cancer cells via Rnd1 downregulation. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1842(11). 2087–2095. 24 indexed citations

12.

Liu, Jin, Chuanshan Xu, Jeng‐Fan Lo, et al.. (2012). Activation of rabbit TLR9 by different CpG-ODN optimized for mouse and human TLR9. Comparative Immunology Microbiology and Infectious Diseases. 35(5). 443–451. 17 indexed citations

13.

Liao, Debbie, Ze Liu, W. Wrasidlo, et al.. (2011). Targeted Therapeutic Remodeling of the Tumor Microenvironment Improves an HER-2 DNA Vaccine and Prevents Recurrence in a Murine Breast Cancer Model. Cancer Research. 71(17). 5688–5696. 50 indexed citations

14.

Liao, Debbie, Ze Liu, Wolfgang Wrasidlo, et al.. (2011). Synthetic enzyme inhibitor: a novel targeting ligand for nanotherapeutic drug delivery inhibiting tumor growth without systemic toxicity. Nanomedicine Nanotechnology Biology and Medicine. 7(6). 665–673. 54 indexed citations

15.

Liu, Jin, Chuanshan Xu, Li‐Chung Hsu, et al.. (2009). A five-amino-acid motif in the undefined region of the TLR8 ectodomain is required for species-specific ligand recognition. Molecular Immunology. 47(5). 1083–1090. 91 indexed citations

16.

Lewén, Susanna, He Zhou, Huaidong Hu, et al.. (2007). A Legumain-based minigene vaccine targets the tumor stroma and suppresses breast cancer growth and angiogenesis. Cancer Immunology Immunotherapy. 57(4). 507–515. 77 indexed citations

17.

Luo, Yunping, He Zhou, Joerg Krueger, et al.. (2006). Targeting tumor-associated macrophages: A novel strategy against breast cancer.. Cancer Research. 66. 1307–1307. 1 indexed citations

18.

Luo, Yunping, Dorothy Markowitz, Rong Xiang, He Zhou, & Ralph A. Reisfeld. (2006). FLK-1-based minigene vaccines induce T cell-mediated suppression of angiogenesis and tumor protective immunity in syngeneic BALB/c mice. Vaccine. 25(8). 1409–1415. 15 indexed citations

19.

Zhou, He, Yunping Luo, Masato Mizutani, et al.. (2004). A novel transgenic mouse model for immunological evaluation of carcinoembryonic antigen–based DNA minigene vaccines. Journal of Clinical Investigation. 113(12). 1792–1798. 26 indexed citations

20.

Reisfeld, Ralph A., Andreas G. Niethammer, Yunping Luo, & Rong Xiang. (2004). DNA Vaccines Designed to Inhibit Tumor Growth by Suppression of Angiogenesis. International Archives of Allergy and Immunology. 133(3). 295–304. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact